Structure-activity relationships study of angiotensin-converting enzyme inhibitor captopril derivatives
β Scribed by C.N. Yoon
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 115 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0263-7855
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The structure of ancovenin, enzyme, was determined to be a unique residues including dehydroalanine and Fujirebio Inc., Ube, Yamaguchi 759-02, Japan a new peptide inhibitor of angiotensin I converting tricyclic peptide which comprises sixteen amino acid three sulfide amino acids as unusual component
In the present study, captopril-loaded ordered mesoporous SBA-15 silica matrix were produced, functionalized, and characterized to obtain an efficient formulation of controlled drug delivery system. First, the starting SBA-15 materials are examined to verify that their synthesis has been successful
Dansylated tight-binding inhibitors are effective fluorophoric probes for detecting conformational changes of enzyme active sites. In this study they have been employed to examine the effect of anions on the conformation of angiotensin-converting enzyme. The efficiency of radiationless energy transf
Probing the Importance of Spacial and Conformational Domains in Captopril Analogues for Angiotensin Converting Enzyme Activity. -An improved large-scale synthesis of 4,5-methano-prolines (IV) and (V) and the enzymatic activity of the corresponding N-(3-mercapto-2-methyl-propionyl) derivatives, e.g.